Abstract:Our study suggests that exome sequencing adds approximately 60% of the diagnostic yield in fetuses with skeletal abnormalities reported in previous literature. The dysplasia phenotypes had a higher incremental yield, whereas the dysostoses group according to this study had a relatively lower yield, especially in the isolated dysostoses group. Such differences may result from pathogenic mechanisms. Identifying these phenotypes is important for diagnosis, prognosis, and clinical consultation. Introduction Fetal skeletal abnormalities can be caused by various factors and genetic cause plays an important role. Prenatal exome sequencing (ES) has been shown to be a powerful approach for accurate prenatal molecular diagnoses. Diagnostic yield of ES in fetal skeletal abnormalities varies significantly across studies. This study aimed to perform a systematic review of the literature and meta‐analysis to assess the incremental yield of ES in fetuses with different kinds of skeletal abnormalities and a negative result on chromosome microarray or karyotyping. Material and Methods The PubMed, Embase, Web of Science, and Cochrane Library databases were systematically searched up to November 26, 2022. Relevant data were collected from observational studies containing five or more cases of skeletal abnormalities who underwent ES. The incremental yield of ES was evaluated by single proportion analysis and 95% confidence interval (CI), both according to the article features and individual phenotypes. This study was registered on PROSPERO as CRD42022382800. Results Twenty‐six studies including 524 individuals met the inclusion criteria. The pooled incremental yield was 60.2% (95% CI, 53.4%–66.9%) for all fetuses with skeletal abnormalities. In subgroup analysis, the additional diagnostic yield was 83.9% (95% CI, 76.4%–90.4%) in isolated dysplasia cases (group I), 52.0% (95% CI, 32.9%–70.9%) in dysplasia with non‐skeletal abnormalities cases (group II), 33.3% (95% CI, 19.3%–48.6%) in isolate dysostoses cases (group III), 47.8% (95 % CI, 35.8%–60.0%) in dysostoses with non‐skeletal abnormalities cases (group IV), 83.0% (95% CI, 63.7%–97.1%) in combination of the two phenotypes without non‐skeletal abnormalities cases (group V), 74.5% (95% CI, 54.9%–90.9%) in combination of the two phenotypes with non‐skeletal abnormalities cases (group VI). The origin of the pathogenic variations differed among the groups. Most causative variants were de novo in groups I (97/133, 72.9%), V (14/23, 60.9%), and VI (15/26, 57.7%). Meanwhile, pathogenic variations in III (18/25, 72.0%) and IV (37/67, 55.2%) were more often inherited from a parent. Conclusions ES had a favorable incremental yield in fetuses with skeletal abnormalities. The common pathogenic variations and genetic patterns of skeletal abnormalities vary among different subtypes. Interpreting this difference is beneficial for personalized clinical consultation.

Combined Exome Sequencing and Deep Phenotyping in Highly Selected Fetuses with Skeletal Dysplasia During the First and Second Trimesters Improves Diagnostic Yield

Prenatal Trio-Based Whole Exome Sequencing in Fetuses with Abnormalities of the Skeletal System

Whole Exome Sequencing Aids the Diagnosis of Fetal Skeletal Dysplasia

Molecular Diagnosis for 55 Fetuses with Skeletal Dysplasias by Whole‐exome Sequencing: A Retrospective Cohort Study

Exome sequencing in fetuses with short long bones detected by ultrasonography: A retrospective cohort study

Rapid prenatal diagnosis of skeletal dysplasia using medical trio exome sequencing: Benefit for prenatal counseling and pregnancy management

Prenatal diagnosis of skeletal dysplasias using whole exome sequencing in China

Incremental yield of prenatal exome sequencing in fetuses with skeletal system abnormalities: A systematic review and meta‐analysis

Application of exome sequencing for prenatal diagnosis of fetal structural anomalies: clinical experience and lessons learned from a cohort of 1618 fetuses

Whole exome sequencing as a diagnostic adjunct to clinical testing in fetuses with structural abnormalities

Prenatal diagnosis of fetal skeletal anomalies via whole-exome sequencing in a tertiary referral center

Application of Targeted Exome Capture in Identifying Fetal Skeletal Malformation Mutations

Diagnostic Yield of Exome Sequencing in Fetuses with Sonographic Features of Skeletal Dysplasias but Normal Karyotype or Chromosomal Microarray Analysis: A Systematic Review

Clinical exome sequencing for fetuses with ultrasound abnormalities and a suspected Mendelian disorder

Development and validation of an expanded targeted sequencing panel for non-invasive prenatal diagnosis of sporadic skeletal dysplasia

Clinical Application of Medical Exome Sequencing for Prenatal Diagnosis of Fetal Structural Anomalies.

Prenatal exome sequencing for morphologically normal fetus: Should we be doing it?

A pilot study of gene testing of genetic bone dysplasia using targeted next-generation sequencing

Genetics Evaluation of Targeted Exome Sequencing in 223 Chinese Probands with Genetic Skeletal Dysplasias.

Targeted Next-Generation Sequencing Identifies Novel Compound Heterozygous Mutations of DYNC2H1 in a Fetus with Short Rib-Polydactyly Syndrome, Type III

Comprehensive genome sequencing analysis as a promising option in the prenatal diagnosis of fetal structural anomalies: a prospective study